Work

Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha‐2b in metastatic melanoma (phase II DeCOG trial)

Year: 2013

Type: article

Source: JDDG Journal der Deutschen Dermatologischen Gesellschaft

DOI: 10.1111/ddg.12100

Authors: Annette Degen, Michael Weichenthal, Selma Ugurel, Uwe Trefzer, Katharina Kilian, Claus Garbe, Friederike Egberts, Lìdia Marilia Poppe, Axel Hauschild, Ralf Gutzmer

Institutions: Medizinische Hochschule Hannover, University Hospital Schleswig-Holstein, University of Graz, Universitätsklinikum Würzburg, Charité – Universitätsmedizin Berlin, LMU Klinikum, Ludwig-Maximilians-Universität München, Universitätsklinikum Tübingen

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1535011663

FWCI: 2.112

Cites: 32

Cited by: 12

Related to: 10